|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||160.34 - 162.08|
|52 Week Range||133.65 - 173.65|
|Beta (5Y Monthly)||0.72|
|PE Ratio (TTM)||29.34|
|Earnings Date||Apr 20, 2021|
|Forward Dividend & Yield||4.04 (2.51%)|
|Ex-Dividend Date||Feb 22, 2021|
|1y Target Est||185.44|
It’s mainly the younger generations who are testing positive for the coronavirus, and health experts are attributing it to the fact that they are more likely to still be unvaccinated.
University of Alabama at Birmingham Associate Dean for Global Health Dr. Michael Saag joins Yahoo Finance Live to discuss the latest spike in COVID-19 cases.
Is JNJ stock a buy now that the Food and Drug Administration has authorized its one-shot coronavirus vaccine for emergency use? Shares are now forming a new chart pattern.